Principal Financial Group Inc. Purchases Shares of 281,349 Cantel Medical Corp. (CMD)
Principal Financial Group Inc. purchased a new position in shares of Cantel Medical Corp. (NYSE:CMD) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 281,349 shares of the company’s stock, valued at approximately $21,919,000. Principal Financial Group Inc. owned 0.68% of Cantel Medical Corp. at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently modified their holdings of CMD. Integrated Investment Consultants LLC purchased a new stake in Cantel Medical Corp. during the 2nd quarter worth about $161,000. LS Investment Advisors LLC purchased a new stake in Cantel Medical Corp. during the 2nd quarter worth about $172,000. Airain ltd purchased a new stake in Cantel Medical Corp. during the 2nd quarter worth about $201,000. SG Americas Securities LLC purchased a new stake in Cantel Medical Corp. during the 2nd quarter worth about $230,000. Finally, First Quadrant L P CA purchased a new stake in Cantel Medical Corp. during the 2nd quarter worth about $233,000. Institutional investors own 84.28% of the company’s stock.
Several brokerages have weighed in on CMD. Zacks Investment Research upgraded Cantel Medical Corp. from a “sell” rating to a “hold” rating in a report on Tuesday, August 8th. Sidoti raised Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 price objective for the company in a research report on Wednesday, August 2nd. Benchmark Co. cut Cantel Medical Corp. from a “buy” rating to a “hold” rating in a research report on Friday, June 9th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cantel Medical Corp. in a research report on Thursday, June 8th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Cantel Medical Corp. currently has a consensus rating of “Hold” and a consensus target price of $91.67.
In other Cantel Medical Corp. news, Chairman Charles M. Diker sold 35,000 shares of the firm’s stock in a transaction dated Wednesday, July 12th. The stock was sold at an average price of $75.52, for a total value of $2,643,200.00. Following the transaction, the chairman now directly owns 3,114,520 shares of the company’s stock, valued at $235,208,550.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 14.90% of the company’s stock.
Cantel Medical Corp. (NYSE:CMD) opened at 82.68 on Wednesday. The stock’s 50 day moving average price is $76.99 and its 200 day moving average price is $76.58. Cantel Medical Corp. has a 52-week low of $68.19 and a 52-week high of $88.81. The firm has a market capitalization of $3.43 billion, a PE ratio of 48.92 and a beta of 1.23.
Cantel Medical Corp. Company Profile
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Want to see what other hedge funds are holding CMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cantel Medical Corp. (NYSE:CMD).
Receive News & Stock Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related stocks with our FREE daily email newsletter.